Thursday, September 10, 2026

Schizophrenia Pharmacology Solution Spaces

Meshnet Run 413-Epsilon: Schizophrenia Pharmacology Solution Spaces

1. Synaptic Pruning Inhibitor (C4a Target)

Etiology: Over-expression of the Complement C4A gene tags healthy synapses for destruction, causing microglia to aggressively "over-prune" the prefrontal cortex.

Meshnet Logic: Overhauled mapped the C4/C3 convertase interface, isolating a small molecule that sterically blocks the C4 tag from binding to microglial receptors.

Generated SMILES String: CC1=C(C=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(F)(F)F)C(=O)NC3=NC=CS3
YuKKi OS Spatial Sync: Active Target: C4/C3 Convertase Cleft Etiology: MHC Locus C4a Over-expression Mechanism: Steric Receptor Blockade Microglial Receptor Interface NH S O CH3 CF3
[Q32.32 Vector Space]

2. PV-Interneuron Epigenetic Modulator

Etiology: Hyper-methylation and histone deacetylation at the GAD1 promoter silences genes necessary for parvalbumin (PV) interneuron function.

Meshnet Logic: A distributed QM/MM simulation of the HDAC3 active site generated a blood-brain barrier-permeable hydroxamic acid to restore local gene expression.

Generated SMILES String: CN(C)C(=O)C1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)N(O)C=O
YuKKi OS Spatial Sync: Active Target: Histone Deacetylase 3 (HDAC3) Etiology: GAD1 Promoter Desynchrony Mechanism: Catalytic Zn2+ Chelation Zn²⁺ HDAC3 Catalytic Tunnel CH3 N CH3 O NH O HO-NH
[QM/MM Lockstep Active]

3. D2/mGluR2 Heteromer Bridge

Etiology: Dopaminergic hyperactivity in the striatum combined with glutamatergic hypofunction in the cortex.

Meshnet Logic: An allosteric bridge that stabilizes the specific D2/mGluR2 heterodimer, tuning down dopamine while boosting glutamate without motor side effects.

Generated SMILES String: O=C(N1CCN(CC1)C2=CC=CC=C2Cl)C3=CC4=C(C=C3)OCO4
YuKKi OS Spatial Sync: Active Target: D2 / mGluR2 Transmembrane Dimer Etiology: Cortico-Striatal Imbalance Mechanism: Allosteric Heteromer Bridging Dopamine D2 Helix Glutamate mGluR2 Helix Cl N N O O O
[Fixed-Point Sync: 60Hz]

No comments:

Post a Comment